SCHEMBL3479739

SCHEMBL3479739

CN1CCN(c2ccc3c(c2)CN(C)CCN3c2ccc(F)c(F)c2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.46
KDM4E B2RXH2 3/20 0.46
MAPT P10636 3/20 0.46
PTK2B Q14289 2/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
RECQL P46063 1/20 0.46
ALDH1A1 P00352 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ADRA2C P18825 2/20 0.41
KMT2A Q03164 3/20 0.41
GFER P55789 1/20 0.41
ESR2 Q92731 1/20 0.41
HTR3A P46098 1/20 0.40
TMEM97 Q5BJF2 3/20 0.39
SIGMAR1 Q99720 3/20 0.39
HTR1A P08908 1/20 0.39
DRD2 P14416 1/20 0.39
ADRA1D P25100 1/20 0.39
ADRA1A P35348 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3228169 0.91 LGMN (0.41) GAAKDM4EMAPTPTK2BMAPK1
SCHEMBL3479783 0.91 ADRB1 (0.40) GAAKDM4EMAPTPTK2BMAPK1
SCHEMBL3228723 0.90 MEN1 (0.43) KMT2AGFERSIGMAR1MEN1
SCHEMBL3229545 0.89 SLC6A2 (0.43) GAAKDM4EMAPTPTK2BMAPK1
SCHEMBL3479611 0.88 ALDH1A1 (0.46) GAAKDM4EMAPTPTK2BMAPK1
SCHEMBL3479640 0.86 ALDH1A1 (0.50) GAAKDM4EMAPTPTK2BMAPK1
SCHEMBL3479697 0.85 SCN9A (0.37) GAAKDM4EMAPTPTK2BMAPK1
SCHEMBL3479763 0.85 GAA (0.47) GAAKDM4EMAPTPTK2BMAPK1
SCHEMBL3239788 0.83 SLC6A2 (0.47) MAPTHTTALDH1A1ADRA2CKMT2A
SCHEMBL3479952 0.83 POLB (0.50) GAAKDM4EMAPTPTK2BMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US disclosed
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ADRA1B, ADRB1, ADRA1D GAA 3775/4885KDM4E 921/4885MAPT 2307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.